Providence, RI, April 06, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA) announced today a strong commitment to targeting its pulmonary fibrosis treatment candidate, “OCF-203,” as a ...
University of Iowa Assistant Professor Yuliang Xie received a grant from the National Institute of Health to develop a lab-on-a-chip invention and help further advancements in fighting and ...
Providence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (OCEA) (NASDAQ: OCEA) today announced newly published research findings demonstrating the ability of its proprietary cancer ...
Dr. Justin Brown of Pennington Biomedical invites patients with lung or gastrointestinal cancers to participate in National Cancer Institute-funded trial. Pennington Biomedical Research Center is ...
Research by UB biomedical engineers Ruogang Zhao and Yun Wu may help discover new drugs to treat pulmonary fibrosis, a severe lung disease that can be life-threatening. Pulmonary fibrosis has many ...
Moncton, New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - June 17, 2025) - Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today ...
ORACLE test predicts overall cancer survival independent of currently used clinical risk factors, and it has the best predictive power in stage 1 lung cancer. A high ORACLE score is associated with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback